1 study found for:    23075178 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy
Condition: Crohn's Disease
Interventions: Drug: Placebo (IP);   Drug: Ustekinumab 1mg/kg (IP);   Drug: Ustekinumab 3 mg/kg (IP);   Drug: Ustekinumab 6 mg/kg (IP);   Drug: Placebo IV - Responder - Placebo SC (MP);   Drug: Placebo IV - Nonresponder - Ustekinumab 270/90 mg SC (MP);   Drug: Ustekinumab IV - Responder - Placebo SC (MP);   Drug: Ustekinumab IV - Responder - Ustekinumab 90mg SC (MP);   Drug: Ustekinumab IV - Nonresponder - Placebo SC (MP);   Drug: Ustekinumab IV - Nonresponder - Ustekinumab 90mg SC (MP)

Indicates status has not been verified in more than two years